Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2024, 33(2):107-115

Genetic predisposition to atrial fibrillation in patients with cardiomyopathy

Martin Kmec1, Michaela Zigová2, Eva Petrejčíková2
1 Kardiocentrum FNsP J. A. Reimana Prešov
2 Katedry biológie, Fakulta humanitných a prírodných vied Prešovská univerzita v Prešove, Prešovská univerzita, Prešov, Slovenská republika

Background: Worldwide, atrial fibrillation (AF) is the most common arrhytmia in all subtypes of cardiomyopathies (CMP). Genetic testing of CMP genes is a standard aspect of clinical management in affected families.

Aim: To determine the association of selected genetic markers of patients with cardiomyopathies and atrial fibrillation in the region of eastern Slovakia.

Patients and methods: After signing informed consent, clinical data and a venous blood sample were obtained from all study participants for genetic analysis. After analyzing the genetic results, allele and genotype frequencies were calculated in the patient group and in the control group. Our case-control study was conducted in a group of 85 individuals from the region of eastern Slovakia, of which 43.53% were patients with CMP and AF with an average age of 62.65 ± 11.01 years. The group was dominated by men (64.71%) and there were more frequent patients with dilated CMP and at the same time with persistent AF.

Results: Representation of potentially risky alleles associated with AF was higher in the case of rs13143308 and rs2220427 in patients with CMP and AF compared to the control group. The potentially risky T allele of the genetic variant rs3853445 dominated in the control group (73% vs. 68%). After evaluating the allelic and genotypic distributions, an analysis of associations of genetic models of variants rs13143308, rs2220427 and rs3853445 with location in the 4q25 locus in relation to cardiomyopathy associated with AF was carried out. None of these analyses confirmed a significant association of the respective genetic model in relation to CMP associated with AF. The p-value of the odds ratio (OR) calculations was higher than 0.05 in all cases Conclusion: By analyzing the selected genetic markers rs13143308, rs2220427 and rs3853445 located in the 4q25 locus, we failed to statistically confirm their association with cardiomyopathy and related atrial fibrillation. Thus, we can conclude that the basic limitation of our study was the size of the research sample.

Keywords: atrial fibrillation; cardiomyopathy; locus; gene; allele; marker

Published: February 1, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kmec M, Zigová M, Petrejčíková E. Genetic predisposition to atrial fibrillation in patients with cardiomyopathy. Cardiology Letters. 2024;33(2):107-115.
Download citation

References

  1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, BlomstromLundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2020;42:373-498. doi:10.1093/eurheartj/ehaa612 Go to original source...
  2. Aguirre LA, Alonso ME, Badîa-Careaga C, Rollán I, Arias C, Fernández-Miñán A, et al. Long-range regulatory interactions at the 4q25 atrial fibrillation risk locus involve PITX2c and ENPEP. BMC Biol 2015;17;13-26. Go to original source...
  3. Hayashi K, Tada H, Yamagishi M. The genetics of atrial fibrillation. Curr Opin Cardiol 2017;32:10-16. Go to original source...
  4. Kalsto SJ, Siland JE, Rienstra M, Christophersen IE. Atrial Fibrillation Genetics Update: Toward Clinical Implementation, Front. Cardiovasc Med 2019;6:1-16. Go to original source...
  5. Zigová M, Petrejčîková E, Mydlárová Blaščáková M, Kmec J, Bernasovská J, Boroňová I, et al. Genetic targets in the management of atrial fibrillation in patients with cardiomyopathy. J Pract Cardiovasc Sci 2022;8:9-16. Go to original source...
  6. Arbelo E, Protonotarius A, Gimeo JR, Arbustini E, Barriales-Villa R, Basso C, et al. 2023 ESC Guidelines for management of cardiomyopathies of the European Society of Cardiology (ESC). Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). Eur Heart J 2023;44:3503-3626. Go to original source...
  7. Miller DT, Lee K, Chung WK, Gordon AS, Herman GE, Klein TE, et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021;23:1381-1390. https://doi.org/10.1038/s41436-021-01172-3 Go to original source...
  8. Miller DT, Lee K, Gordon AS, Amendola LM, Adelman K, Bale SJ, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021;23:1391-1398. https://doi.org/10.1038/s41436-021-01171-4 Go to original source...
  9. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;142:e558-e631. doi: 10.1161/CIR.0000000000000937 Go to original source...
  10. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-276. Go to original source...
  11. Databáza Ensembl (https://www.ensembl.org/index.html)
  12. Sisakian H. Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies. World J Cardiol 2014;6:478-494. doi:10.4330/wjc.v6.i6.478. Go to original source...
  13. Spirito P. Atrial Fibrillation in Hypertrophic Cardiomyopathy New Light on an Old Problem. Circulation 2017;136:24372439. Go to original source...
  14. Bonadei I, Gorga E, Lombardi C, Metra M. Arrhythmias and cardiomyopathy: when arrhythmias come first. J Cardiovasc Med (Hagerstown) 2017;18 Suppl 1:e145-e148. doi: 10.2459/JCM.0000000000000464. Go to original source...
  15. Patten M, Pecha S, Ali Aydin A. Atrial Fibrillation in Hypertrophic Cardiomyopathy: Diagnosis and Considerations for Management. J Atr Fibrillation 2018;10:1556-1562. Go to original source...
  16. Yeung C, Enriquez A, Suarez-Fuster L, Baranchuk A. Atrial fibrillation in patients with inherited cardiomyopathies. Europace. 2019;21:22-32. doi: 10.1093/europace/euy064. Go to original source...
  17. Buckley BJR, Harrison SL, Gupta D, Fazio-Eynullayeva E, Underhill P, Lip GYH. Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real-World Data. J Am Heart Assoc 2021;10:e021970. Go to original source...
  18. Tian T, Wang Y, Sun K, Wang J, Zou Y, Zhang W, et al. Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy. Cardiology 2013;126:258264. doi: 10.1159/000354953. Go to original source...
  19. Aleksova A, Merlo M, Zecchin M, Sabbadini G, Barbati G, Vitrella G, et al. Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the Heart Muscle Disease Registry of Trieste. Clin Med Res 2010;8:142149. doi:10.3121/cmr.2010.908. Go to original source...
  20. Andersen JH, Olesen MS. Genetics of Atrial Fibrillation and Atrial Cardiomyopathy. J Human Clin Gen 2019;1:1-3. Go to original source...
  21. Lozano-Velasco E, Franco D, Aranega A, Daimi H. Genetics and Epigenetics of Atrial Fibrillation. Int J Mol Sci 2020;21:5717. doi:10.3390/ijms21165717. Go to original source...
  22. Hong K, Xiong Q. Genetic basis of atrial fibrillation. Curr Opin Cardiol. 2014;29:220-226. doi: 10.1097/HCO.0000000000000051. Go to original source...
  23. Databáza GWAS catalog dostupná na https://www.ebi.ac.uk/ gwas).
  24. Nielsen JB, Thorolfsdottir RB, Fritsche LG, Zhou W, Skov MW, Graham SE, et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat Genet. 2018;50:12341239. doi:10.1038/s41588-018-0171-3 Go to original source...
  25. Roselli C, Chaffin MD, Weng LC, Aeschbecher S, Ahlberg G, Albert CM, et al. Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet 2018;50:1225-1233. doi:10.1038/s41588-018-0133-9 Go to original source...
  26. Lubitz SA, Sinner MF, Lunetta KL, Makino S, Arne Pfeufer A, Rahman R, et al. Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation 2010;122:976984. Go to original source...
  27. Low SK, Takahashi A, Ebana Y, Ozaki K, Christophersen IE, Ellinir PT, et al. Identification of six new genetic loci associated with atrial fibrillation in the Japanese population. Nat Genet 2017;49:953-958. doi:10.1038/ng.3842 Go to original source...
  28. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007;448:353-357. Go to original source...
  29. Herraiz-Martínez A, Llach A, Tarifa C, Gandia J, Jiménez-Sabado V, Lozano-Velasco E, et al. The 4q25 variant rs13143308T links risk of atrial fibrillation to defective calcium homoeostasis. Cardiovasc Res 2019;115:578-589. doi:10.1093/cvr/cvy215 Go to original source...
  30. Wolff L. Familial auricular fibrillation. N Engl J Med 1943;229:396. Go to original source...
  31. Jiang T, Wang YN, Qu Q, Qi TT, Chen YD, Qu J. Association between gene variants and the recurrence of atrial fibrillation: An updated meta-analysis. Medicine (Baltimore). 2019;98:e15953. doi:10.1097/MD.0000000000015953) Go to original source...
  32. Olesen MS, Nielsen MW, Haunsø S, Svendsen JH. Atrial fibrillation: The role of common and rare genetic variants. Eur J Hum Genet. 2014;22:297-306. doi:10.1038/ejhg.2013.139). Go to original source...
  33. Szegedi I, Szapáry L, Csécsei P, Csanádi Z and Csiba L. Potential Biological Markers of Atrial Fibrillation: A Chance to Prevent Cryptogenic Stroke. Biomed Res Int. 2017;2017:8153024. doi:10.1155/2017/8153024 Go to original source...
  34. O'Neal WT, Venkatesh S, Broughton ST, Griffin WF and Soliman EZ. Biomarkers and the prediction of atrial fibrillation: state of the art. Vasc Health Risk Manag 2016;12:297-303. doi:10.2147/VHRM.S75537 Go to original source...